Researching how to safely and effectively manufacture cells and cell-derived products like exosomes for translational purposes is critical to current regenerative medicine efforts.
Preventing age-related cognitive decline by preserving the integrity of existing CNS neurons and repairing/regenerative damaged ones is at the heart of our Translational Neuroscience Group. We're using cutting-edge neuroregenerative medical technologies to push the envelope of practicality and possibility.
Ischemic heart disease kills more people worldwide every year than anything else and the risk of dying from it increases with age. Preventing heart disease and regenerative aged, damaged vasculature are at the core of our Regenerative Vasculature Medicine research program.
ICR is researching ways to regenerate the aged immune system. Immune senescence and decline underlie many of the most devastating age-related diseases. Our Regenerative Immunology program involves several approaches, including developing bone marrow-engraftable iPSC-derived hematopoietic stem cells (iHSCs) and implantable thymic organoids.
Regenerative medicine is the heart of what we do at ICR, with many parts centered on induced pluripotent stem (iPS) cells, iPS cell-derived stem cells, and their products (e.g. exosomes). We research and develop the most practical, high-impact products to regenerate aging human tissues and prevent age-related disease.
Creative thinking and innovative engineering are needed to accelerate the development of regenerative medicine strategies and interventions to slow biological aging and repair age-related damage. At ICR, our Gene Therapy Scientists and Genetic Engineers will tackle some of the hardest challenges in aging and regenerative medicine.